The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer's disease
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676
Structures of Human Acetylcholinesterase in Complex with Pharmacologically Important Ligands
Cheung, J., Rudolph, M. J., Burshteyn, F., Cassidy, M. S., Gary, E. N., Love, J., Franklin, M. C., & Height, J. J. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300871x · Cited by 1,356
Crystal Structure of Human Butyrylcholinesterase and of Its Complexes with Substrate and Products
Nicolet, Y., Lockridge, O., Masson, P., Fontecilla-Camps, J. C., & Nachon, F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210241200 · Cited by 840
Bartus, R. T. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7397 · Cited by 829
The amyloid hypothesis for Alzheimer’s disease: A critical reappraisal
Hardy, J. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06181.x · Cited by 814
Acetylcholinesterase: From 3D structure to function
Dvir, H., Silman, I., Harel, M., Rosenberry, T. L., & Sussman, J. L. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.01.042 · Cited by 790
Acetylcholine in mind: a neurotransmitter correlate of consciousness?
Perry, E., Walker, M., Grace, J., & Perry, R. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01361-7 · Cited by 763
Resveratrol Promotes Clearance of Alzheimer's Disease Amyloid-β Peptides
Marambaud, P., Zhao, H., & Davies, P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508246200 · Cited by 749
Greig, N. H., Utsuki, T., Ingram, D. K., Wang, Y., Pepeu, G., Scali, C., Yu, Q.-S., Mamczarz, J., Holloway, H. W., Giordano, T., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508575102 · Cited by 734
NITRIC OXIDE SYNTHASE: Role in the Genesis of Vascular Disease
Cooke, M., & Dzau, M. (1997) · Annual Review of Medicine · doi:10.1146/annurev.med.48.1.489 · Cited by 710
Adlard, P. A., Cherny, R. A., Finkelstein, D. I., Gautier, E., Robb, E., Cortes, M., Volitakis, I., Liu, X., Smith, J. P., Perez, K., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.018 · Cited by 672
Self-citationThe Cholinesterases: From Genes to Proteins
Taylor, P., & Radic, Z. (1994) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.34.040194.001433 · Cited by 669
Mesulam, M.-M., Guillozet, A., Shaw, P., Levey, A., Duysen, E. G., & Lockridge, O. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00613-3 · Cited by 650
ALZHEIMER'S DISEASE INTERNATIONAL
GRAHAM, N., & BRODATY, H. (1997) · International Journal of Geriatric Psychiatry · doi:10.1002/(sici)1099-1166(199707)12:7<691::aid-gps648>3.0.co;2-f · Cited by 634
Comparison of butyrylcholinesterase and acetylcholinesterase
Chatonnet, A., & Lockridge, O. (1989) · Biochemical Journal · doi:10.1042/bj2600625 · Cited by 549
A New Therapeutic Target in Alzheimer's Disease Treatment: Attention to Butyrylcholinesterase
Greig, N. H., Utsuki, T., Yu, Q.-S., Zhu, X., Holloway, H. W., Perry, T., Lee, B., Ingram, D. K., & Lahiri, D. K. (2001) · Current Medical Research and Opinion · doi:10.1185/03007990152673800 · Cited by 493
Structure, function and regulation of carboxylesterases
Satoh, T., & Hosokawa, M. (2006) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2006.07.001 · Cited by 488
REVIEW: Curcumin and Alzheimer’s disease
Hamaguchi, T., Ono, K., & Yamada, M. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00147.x · Cited by 450
Acetylcholinesterase in Alzheimer's disease
Talesa, V. N. (2001) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(01)00309-8 · Cited by 450
8-Hydroxyquinolines: a review of their metal chelating properties and medicinal applications
Prachayasittikul, V., Prachayasittikul, V., Prachayasittikul, S., & Ruchirawat, S. (2013) · Drug Design, Development and Therapy · doi:10.2147/dddt.s49763 · Cited by 445
Lockridge, O. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.011 · Cited by 420
Chyan, Y.-J., Poeggeler, B., Omar, R. A., Chain, D. G., Frangione, B., Ghiso, J., & Pappolla, M. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.31.21937 · Cited by 405
Structure, Function, and Regulation of Carboxylesterases
Hosokawa, M., & Satoh, T. (2006) · Toxicology of Organophosphate & Carbamate Compounds · doi:10.1016/b978-012088523-7/50017-x · Cited by 374
Resveratrol—A boon for treating Alzheimer's disease?
Anekonda, T. S. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.04.004 · Cited by 339
Mushtaq, G., Greig, N., Khan, J., & Kamal, M. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666141023141545 · Cited by 331
MicroRNAs (miRNAs) in Neurodegenerative Diseases
Nelson, P. T., Wang, W., & Rajeev, B. W. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00120.x · Cited by 326
Arendt, T., Brückner, M. K., Lange, M., & Bigl, V. (1992) · Neurochemistry International · doi:10.1016/0197-0186(92)90189-x · Cited by 314
Widely spread butyrylcholinesterase can hydrolyze acetylcholine in the normal and Alzheimer brain
Mesulam, M., Guillozet, A., Shaw, P., & Quinn, B. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0462 · Cited by 314
Kornhuber, J., Bormann, J., Hübers, M., Rusche, K., & Riederer, P. (1991) · European Journal of Pharmacology: Molecular Pharmacology · doi:10.1016/0922-4106(91)90113-v · Cited by 308
Brus, B., Košak, U., Turk, S., Pišlar, A., Coquelle, N., Kos, J., Stojan, J., Colletier, J.-P., & Gobec, S. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501195e · Cited by 285
Memantine: A Review of Its Use in Alzheimer’s Disease
Robinson, D. M., & Keating, G. M. (2006) · Drugs · doi:10.2165/00003495-200666110-00015 · Cited by 277
Fernández-Bachiller, M. I., Pérez, C., González-Muñoz, G. C., Conde, S., López, M. G., Villarroya, M., García, A. G., & Rodríguez-Franco, M. I. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100329q · Cited by 268
Fernández-Bachiller, M. I., Pérez, C., Monjas, L., Rademann, J., & Rodríguez-Franco, M. I. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201460y · Cited by 268
Finberg, J. P. M. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.02.010 · Cited by 257
Xie, W., Stribley, J. A., Chatonnet, A., Wilder, P. J., Rizzino, A., McComb, R. D., Taylor, P., Hinrichs, S. H., & Lockridge, O. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39312-7 · Cited by 255
Hydrolysis of cocaine in human plasma by cholinesterase
Stewart, D. J., Inaba, T., Tang, B. K., & Kalow, W. (1977) · Life Sciences · doi:10.1016/0024-3205(77)90448-9 · Cited by 221
Antihistamine Agent Dimebon As a Novel Neuroprotector and a Cognition Enhancer
BACHURIN, S., BUKATINA, E., LERMONTOVA, N., TKACHENKO, S., AFANASIEV, A., GRIGORIEV, V., GRIGORIEVA, I., IVANOV, Y., SABLIN, S., & ZEFIROV, N. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03654.x · Cited by 219
ALZHEIMER'S DISEASE INTERNATIONAL
Graham, N., & Brodaty, H. (1997) · International Journal of Geriatric Psychiatry · doi:10.1002/(sici)1099-1166(199707)12:7<691::aid-gps648>3.3.co;2-6 · Cited by 213
Oxidative Stress in Alzheimer’s Disease: Are We Connecting the Dots?: Miniperspective
Rosini, M., Simoni, E., Milelli, A., Minarini, A., & Melchiorre, C. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm400970m · Cited by 201
The atypical antidepressant and neurorestorative agent tianeptine is a μ-opioid receptor agonist
Gassaway, M. M., Rives, M.-L., Kruegel, A. C., Javitch, J. A., & Sames, D. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.30 · Cited by 195
Shafferman, A., Kronman, C., Flashner, Y., Leitner, M., Grosfeld, H., Ordentlich, A., Gozes, Y., Cohen, S., Ariel, N., & Barak, D. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)37091-7 · Cited by 190
Overview of the Chemistry of 2-Thiazolines
Gaumont, A.-C., Gulea, M., & Levillain, J. (2009) · Chemical Reviews · doi:10.1021/cr800189z · Cited by 189
Luo, Z., Sheng, J., Sun, Y., Lu, C., Yan, J., Liu, A., Luo, H.-B., Huang, L., & Li, X. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401047q · Cited by 177
Berne, C., Gunnarsson, R., Hellerström, C., & Wilander, E. (1974) · The Lancet · doi:10.1016/s0140-6736(74)92474-x · Cited by 175
Decker, M. W. (2005) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2004.12.003 · Cited by 166
Darvesh, S., Darvesh, K. V., McDonald, R. S., Mataija, D., Walsh, R., Mothana, S., Lockridge, O., & Martin, E. V. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8002075 · Cited by 159
Xie, S.-S., Wang, X., Jiang, N., Yu, W., Wang, K. D. G., Lan, J.-S., Li, Z.-R., & Kong, L.-Y. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.03.040 · Cited by 158
Carlier, P. R., Han, Y., Chow, E. S. ‐., et al. (1999) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(98)00213-2 · Cited by 158
Dighe, S. N., Deora, G. S., la Mora, E. D., Nachon, F., Chan, S., Parat, M., Brazzolotto, X., & Ross, B. P. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00356 · Cited by 158
Mack, A., & Robitzki, A. A. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00047-7 · Cited by 156
Carboxylesterases - Detoxifying Enzymes and Targets for Drug Therapy
Potter, P. M., & Wadkins, R. M. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706776360969 · Cited by 150
Savini, L., Gaeta, A., Fattorusso, C., Catalanotti, B., Campiani, G., Chiasserini, L., Pellerano, C., Novellino, E., McKissic, D., & Saxena, A. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0255668 · Cited by 148
Park, C., Kim, S., Choi, W., Lee, Y. J., Kim, J., Kang, S. S., & Sun, Y. (1996) · Planta Medica · doi:10.1055/s-2006-957926 · Cited by 143
Zha, X., Lamba, D., Zhang, L., Lou, Y., Xu, C., Kang, D., Chen, L., Xu, Y., Zhang, L., Simone, A. D., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01119 · Cited by 140
Brazzolotto, X., Wandhammer, M., Ronco, C., Trovaslet, M., Jean, L., Lockridge, O., Renard, P., & Nachon, F. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08672.x · Cited by 126
Manoharan, I., Boopathy, R., Darvesh, S., & Lockridge, O. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2006.11.005 · Cited by 122
Methylene blue and dimebon inhibit aggregation of TDP‐43 in cellular models
Yamashita, M., Nonaka, T., Arai, T., Kametani, F., Buchman, V. L., Ninkina, N. N., Бачурин, С. О., Akiyama, H., Goedert, M., & Hasegawa, M. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.06.042 · Cited by 116
Association between butyrylcholinesterase activity and low-grade systemic inflammation
Lampón, N., Hermida-Cadahía, E. F., Riveiro, A., & Tutor, J. C. (2012) · Annals of Hepatology · doi:10.1016/s1665-2681(19)30932-9 · Cited by 116
Relationship between serum butyrylcholinesterase and the metabolic syndrome
Randell, E. W., Mathews, M. S., Zhang, H., et al. (2005) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2005.04.008 · Cited by 110
Darras, F. H., Kling, B., Heilmann, J., & Decker, M. W. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml3001825 · Cited by 108
The Butyrylcholinesterase Knockout Mouse as a Model for Human Butyrylcholinesterase Deficiency
Li, B., Duysen, E. G., Carlson, M., & Lockridge, O. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.133330 · Cited by 107
Махаева, Г. Ф., Lushchekina, S. V., Boltneva, N. P., Sokolov, V. B., Grigoriev, V. V., Serebryakova, O. G., Vikhareva, E. A., Aksinenko, A. Y., Barreto, G. E., Aliev, G., et al. (2015) · Scientific Reports · doi:10.1038/srep13164 · Cited by 105
Wu, M., Esteban, G., Brogi, S., Shionoya, M., Wang, L., Campiani, G., Unzeta, M., Inokuchi, T., Butini, S., & Marco‐Contelles, J. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.10.001 · Cited by 104
Sawatzky, E., Wehle, S., Kling, B., Wendrich, J., Bringmann, G., Sotriffer, C., Heilmann, J., & Decker, M. W. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01674 · Cited by 103
Decker, M. W. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060682m · Cited by 101
Ogunkeye, O. O., & Roluga, A. I. (2006) · Pathophysiology · doi:10.1016/j.pathophys.2006.01.002 · Cited by 97
Li, S., Jiang, N., Xie, S., Wang, K. D. G., Wang, X., & Kong, L. (2013) · Organic & Biomolecular Chemistry · doi:10.1039/c3ob42010h · Cited by 97
Abbott, C. A., Mackness, M., Kumar, S., Olukoga, A. O., Gordon, C., Arrol, S., Bhatnagar, D., Boulton, A. J. M., & Durrington, P. N. (1993) · Clinical Science · doi:10.1042/cs0850077 · Cited by 96
Григорьев, В. В., Dranyi, O. A., & Бачурин, С. О. (2003) · Bulletin of Experimental Biology and Medicine · doi:10.1023/b:bebm.0000017097.75818.14 · Cited by 96
DECREASED RATIO OF CSF ACETYLCHOLINESTERASE TO BUTYRYLCHOLINESTERASE ACTIVITY IN ALZHEIMER'S DISEASE
Arendt, T., Bigl, V., Walther, F., & Sonntag, M. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90116-8 · Cited by 96
An update on amine oxidase inhibitors: Multifaceted drugs
Song, M.-S., Matveychuk, D., MacKenzie, E. M., Duchcherer, M., Mousseau, D. D., & Baker, G. B. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.02.001 · Cited by 94
Tunek, A., & Svensson, L.-Å. (1988) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07050-3 · Cited by 93
Prati, F., Bergamini, C., Fato, R., Soukup, O., Korábečný, J., Andrisano, V., Bartolini, M., & Bolognesi, M. L. (2016) · ChemMedChem · doi:10.1002/cmdc.201600014 · Cited by 91
Zhang, C., Du, Q.-Y., Chen, L.-D., Wu, W., Liao, S., Yu, L., & Liang, X. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.03.077 · Cited by 89
Calderon‐Margalit, R., Adler, B., Abramson, J. H., et al. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.059857 · Cited by 88
Clioquinol-Zinc Chelate: A Candidate Causative Agent of Subacute Myelo-Optic Neuropathy
Arbiser, J. L., Kraeft, S.-K., van Leeuwen, R., Hurwitz, S. J., Selig, M., Dickersin, G. R., Flint, A., Byers, H. R., & Chen, L. B. (1998) · Molecular Medicine · doi:10.1007/bf03401927 · Cited by 85
Therapeutic Use of Butyrylcholinesterase for Cocaine Intoxication
Mattes, C. E., Lynch, T. J., Singh, A., Bradley, R. M., Kellaris, P. A., Brady, R. O., & Dretchen, K. L. (1997) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1997.8188 · Cited by 85
Wang, J., Wang, Z., Li, X., Li, F., Wu, J., Kong, L., & Wang, X. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.07.025 · Cited by 83
Giorgetti, M., Gibbons, J. A., Bernales, S., Alfaro, I. E., Rochelle, C. D. L., Cremers, T. I. F. H., Altar, C. A., Wronski, R., Hutter‐Paier, B., & Protter, A. A. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.164491 · Cited by 80
Yu, Q., Holloway, H. W., Flippen-Anderson, J. L., Hoffman, B., Brossi, A. R., & Greig, N. H. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010080x · Cited by 79
Santarpia, L., Alfonsi, L., Pasanisi, F., Caprio, C. D., Scalfi, L., & Contaldo, F. (2006) · Nutrition · doi:10.1016/j.nut.2005.06.011 · Cited by 78
Lan, J., Xie, S., Li, S., Pan, L.-F., Wang, X., & Kong, L. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.08.035 · Cited by 77
Yanovsky, I., Finkin-Groner, E., Zaikin, A., Lerman, L., Shalom, H., Zeeli, S., Weill, T., Ginsburg, I., Nudelman, A., & Weinstock, M. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301411g · Cited by 77
Acetylcholinesterase and butyrylcholinesterase as markers of low-grade systemic inflammation
Das, U. N. (2012) · Annals of Hepatology · doi:10.1016/s1665-2681(19)30940-8 · Cited by 77
Chojnacki, J. E., Liu, K., Yan, X., Toldo, S. A., Selden, T. M., Estrada, M., Rodríguez-Franco, M. I., Halquist, M. S., Ye, D., & Zhang, S. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn500081s · Cited by 76
Špilovská, K., Korábečný, J., Král, J., Horova, A., Musílek, K., Soukup, O., Drtinová, L., Gažová, Z., Šipošová, K., & Kuča, K. (2013) · Molecules · doi:10.3390/molecules18022397 · Cited by 73
2-Arylbenzofuran-based molecules as multipotent Alzheimer's disease modifying agents
Rizzo, S., Tarozzi, A., Bartolini, M., Costa, G. D., Bisi, A., Gobbi, S., Belluti, F., Ligresti, A., Allarà, M., Monti, J., et al. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.10.045 · Cited by 71
Valle, A. M., O’Connor, D. T., Taylor, P., Zhu, G., Montgomery, G. W., Slagboom, P. E., Martin, N. G., & Whitfield, J. B. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.065052 · Cited by 71
Carolan, C. G., Dillon, G. P., Khan, D., Ryder, S. A., Gaynor, J. M., Reidy, S., Marquez, J. F., Jones, M., Holland, V., & Gilmer, J. F. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm9014845 · Cited by 70
The experimental Alzheimer drug phenserine: preclinical pharmacokinetics and pharmacodynamics
Greig, N. H., Micheli, E. D., Holloway, H. W., Yu, Q.-S., Utsuki, T., Perry, T., Ingram, D. K., Deutsch, J., Lahiri, D. K., & Soncrant, T. T. (2000) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2000.00311.x · Cited by 70
Serum pseudocholinesterase and very‐low‐density lipoprotein metabolism
Kutty, K. M., & Payne, R. H. (1994) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.1860080411 · Cited by 67
The rationale behind cholinergic drug treatment for dementia related to cerebrovascular disease
Grantham, C., & Geerts, H. (2002) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00274-5 · Cited by 64
Is hippocampal atrophy a future drug target?
Dhikav, V., & Anand, K. S. (2007) · Medical Hypotheses · doi:10.1016/j.mehy.2006.09.040 · Cited by 63
Махаева, Г. Ф., Boltneva, N. P., Lushchekina, S. V., Serebryakova, O. G., Stupina, T. S., Terentiev, A. A., Serkov, I. V., Proshin, A. N., Бачурин, С. О., & Richardson, R. J. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.01.031 · Cited by 61
Knez, D., Brus, B., Coquelle, N., Sosič, I., Šink, R., Brazzolotto, X., Mravljak, J., Colletier, J., & Gobec, S. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.06.010 · Cited by 60
Anti-Bacteroides fragilis substance from Rhubarb
Cyong, J., Matsumoto, T., Kazuo, A., Kiyohara, H., Haruki, Y., & Otsuka, Y. (1987) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(87)90005-5 · Cited by 60
Lin, M., Chung, J., Lu, Y.-C., Yang, C., & Chen, S. (2008) · Oral Oncology · doi:10.1016/j.oraloncology.2008.07.012 · Cited by 60
BACE Inhibitors as Potential Drugs for the Treatment of Alzheimers Disease: Focus on Bioactivity
Evin, G. M., Lessène, G., & Wilkins, S. (2011) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488911795933938 · Cited by 59
Cyclophostin, acetylocholinesterase inhibitor from Streptomyces lavendulae.
KUROKAWA, T., Suzuki, K., Hayaoka, T., Nakagawa, T., IZAWA, T., Kobayashi, M., & HARADA, N. (1993) · The Journal of Antibiotics · doi:10.7164/antibiotics.46.1315 · Cited by 59
de Candia, M., Zaetta, G., Denora, N., Tricarico, D., Majellaro, M., Cellamare, S., & Altomare, C. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.09.037 · Cited by 59
Degradation of acetylcholine in human airways: role of butyrylcholinesterase
Norel, X., Angrisani, M., Labat, C., Gorenne, I., Dulmet, É., Rossi, F., & Brink, C. (1993) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1993.tb13486.x · Cited by 55
Luo, W., Yu, Q., Zhan, M., Parrish, D. A., Deschamps, J. R., Kulkarni, S. S., Holloway, H. W., Alley, G. M., Lahiri, D. K., Brossi, A. R., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049309+ · Cited by 55
Laboratory assessment of nutritional status
Burritt, M. F., & Anderson, C. E. (1984) · Human Pathology · doi:10.1016/s0046-8177(84)80052-0 · Cited by 54
Francis, P. T., Parsons, C. G., & Jones, R. W. (2012) · Expert Review of Neurotherapeutics · doi:10.1586/ern.12.124 · Cited by 54
Rustemeijer, C., SCHOUTEN, J. A., Voerman, H. J., Beynen, A. C., Donker, A. J. M., & Heine, R. J. (2001) · Clinical Science · doi:10.1042/cs1010029 · Cited by 52
Savini, L., Campiani, G., Gaeta, A., Pellerano, C., Fattorusso, C., Chiasserini, L., Fedorko, J. M., & Saxena, A. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00294-3 · Cited by 52
Hu, J., Zhang, M., Yu, L., & Ju, Y. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.06.079 · Cited by 49
Curcumin and Alzheimer Disease: This Marriage Is Not to Be Performed
Mancuso, C., Siciliano, R., & Barone, E. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.l110.133520 · Cited by 45
Present state and future development of the therapy of Alzheimer disease
Pomponi, M. F. L., Giacobini, E., & Brufani, M. (1990) · Aging Clinical and Experimental Research · doi:10.1007/bf03323906 · Cited by 43
Ceschi, M. A., da Costa, J. S., Lopes, J. P. B., Câmara, V. S., Campo, L. F., Borges, A. C. D. A., Gonçalves, C. A., de Souza, D. F., Konrath, E. L., Karl, A. L. M., et al. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.06.025 · Cited by 43
Butyrylcholinesterase activity and metabolic syndrome in obese patients
Alcântara, V. M., Oliveira, L. C., Réa, R. R., Suplicy, H. L., & Chautard-Freire-Maia, E. A. (2005) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2005.048 · Cited by 41
Della, F. P., Abelaira, H. M., Réus, G. Z., Antunes, A. R., dos Santos, M. A. B., Zappellini, G., Steckert, A. V., Vuolo, F. S., Galant, L. S., Dal‐Pizzol, F., et al. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.09.018 · Cited by 39
de Costa, B. R., Dominguez, C., He, X. S., Williams, W. E., Radesca, L. A., & Bowen, W. D. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00101a011 · Cited by 38
Han, F. S., Osajima, H., Cheung, M., Tokuyama, H., & Fukuyama, T. (2007) · Chemistry - A European Journal · doi:10.1002/chem.200601446 · Cited by 36
ACETYLCHOLINESTERASE ACTIVITY CHANGES ON VISCERAL ORGANS OF VMH LESION–INDUCED OBESE RATS
Paes, A. M. D. A., Carniatto, S. R., Francisco, F. A., Brito, N. A., & Mathias, P. C. D. F. (2006) · International Journal of Neuroscience · doi:10.1080/00207450600920910 · Cited by 33
Rosini, M., Simoni, E., Bartolini, M., Soriano, E., Marco, J. L., Andrisano, V., Monti, B., Windisch, M., Hutter‐Paier, B., McClymont, D. W., et al. (2013) · ChemMedChem · doi:10.1002/cmdc.201300263 · Cited by 31
Quinoxaline Derivatives: Novel and Selective Butyrylcholinesterase Inhibitors
Zeb, A., Hameed, A., Khan, L. U., Khan, I., Dalvandi, K., Choudhary, M. I., & Basha, F. Z. (2014) · Medicinal Chemistry · doi:10.2174/1573406410666140526145429 · Cited by 28
Resveratrol Derived Butyrylcholinesterase Inhibitors
Csük, R., Albert, S., Kluge, R., & Ströhl, D. (2013) · Archiv der Pharmazie · doi:10.1002/ardp.201300051 · Cited by 27
Chen, Y., Sun, J., Peng, S., Liao, H., Zhang, Y., & Lehmann, J. (2013) · Archiv der Pharmazie · doi:10.1002/ardp.201300074 · Cited by 25
Self-citationChen, Y., Sun, J., Huang, Z., Liao, H., Peng, S., Lehmann, J., & Zhang, Y. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.03.005 · Cited by 23
Self-citationCucuianu, M., Opincaru, A., & Daniela Tapalag, A. (1978) · Clinica Chimica Acta · doi:10.1016/0009-8981(78)90103-1 · Cited by 22
TAKAHASHI, J. C., Hijikuro, I., Kihara, T., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.01.035 · Cited by 21
Singh, D. P., Borse, S., & Nivsarkar, M. (2016) · Translational research · doi:10.1016/j.trsl.2016.03.014 · Cited by 19
Lin, G., Lee, Y.-R., Liu, Y., & Wu, Y. (2005) · Chemical Research in Toxicology · doi:10.1021/tx050014o · Cited by 17
Rational Approach to an Antiprion Compound with a Multiple Mechanism of Action
Bolognesi, M. L., Bongarzone, S., Aulić, S., Tran, H. N. A., Prati, F., Carloni, P., & Legname, G. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.79 · Cited by 11
Osman, W., Mohamed, T., Sit, V. M.-S., Vasefi, M., Beazely, M. A., & Rao, P. P. N. (2016) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12800 · Cited by 9
Cited by
Sharma, P., Srivastava, P., Seth, A., Tripathi, P. N., Banerjee, A. G., & Shrivastava, S. K. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.12.006 · Cited by 331
Monteiro, A. R., Barbosa, D. J., Remião, F., & Silva, R. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115522 · Cited by 329
Hoffmann, M., Stiller, C., Endres, E., Scheiner, M., Gunesch, S., Sotriffer, C., Maurice, T., & Decker, M. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01012 · Cited by 105
Li, Y., Sang, S., Ren, W., Pei, Y., Bian, Y., Chen, Y., & Sun, H. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113874 · Cited by 77
Self-citationDolles, D., Hoffmann, M., Gunesch, S., Marinelli, O., Möller, J., Santoni, G., Chatonnet, A., Lohse, M. J., Wittmann, H.-J., Strasser, A., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01760 · Cited by 67
Metadata
- Authors
- Li, Q., Yang, H., Chen, Y., & Sun, H.
- Venue
- European Journal of Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2017-05
- Volume
- 132
- Pages
- 294-309
- ISSN
- 0223-5234 (ISSN-L)
- OpenAlex
- W2597990638
- Cited by
- 322
- References
- 126
- FWCI
- 17.01
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.